• Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Pharmaceutical Industry

Pharmaceutical Industry

Page 82 of 100

BRITAIN-PHARMACEUTICAL-GSK
Health

GlaxoSmithKline Fined $54.3 Million for Preventing Generic Competition

By Laura Lorenzetti
February 12, 2016
House Oversight Hearing On Prescription Drug Price Increases
Arts & Entertainment

Martin Shkreli Just Offered Kanye West $10 Million For His New Album

By Ben Geier
February 11, 2016
Coins2Day Global Forum 2015
Leadership

Theranos May Lose Its Biggest Blood-Testing Customer

By Reuters
February 11, 2016
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health

Mylan Reaches $7.2 Billion Deal for Meda

By Laura Lorenzetti
February 10, 2016
Medical Records Archive - IMS Health
Health

This Little-Known Firm Is Getting Rich Off Your Medical Data

By Adam Tanner
February 9, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health

U.S. Is Probing a Possible Half-Billion Dollar Health-Care Fraud

By Michal Addady
February 7, 2016
132093105
MPW

Dear Biopharma Bros, Stop Treating Women Like ‘Chattel’

By Valentina Zarya
February 5, 2016
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
Health

Martin Shkreli Calls U.S. Lawmakers ‘Imbeciles’

By Laura Lorenzetti
February 4, 2016
House Oversight Hearing On Prescription Drug Price Increases
Health

How Martin Shkreli Is ‘Trashing’ the Pharma Industry

By Laura Lorenzetti
February 4, 2016
Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
Health

Martin Shkreli Seriously Didn’t Care About Jacking Up Drug Prices

By Laura Lorenzetti
February 3, 2016
Merck & Co. diabetes treatment Januvia sits is arranged for
Finance

Blockchain Reporter

By Reuters
February 3, 2016
Views Of A CVS Caremark Corp. Store Ahead Of Earns
Retail

CVS Opens First Pharmacies Within Target Stores

By Phil Wahba
February 3, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Top-Selling Prescription Drugs Have Seen Huge Price Hikes

By Claire Groden
February 2, 2016
Symbolic - biotechnology - genetic engineering
Tech

Guess What This Early Skype Investor Is Betting on Now

By Reuters
February 2, 2016
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Leadership

Gilead CEO John Martin Is Stepping Down After 20 Years

By Jen Wieczner
January 29, 2016

Most Popular

  • Economy
    Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House post
    By Eleanor Pringle
  • Investing
    Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the board
    By Jim Edwards
  • Success
    In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
    By Emma Burleigh
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.